Nisa Investment Advisors’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Buy |
6,281
+590
| +10% | +$10.3K | ﹤0.01% | 1365 |
|
|
2025
Q1 | $71.6K | Sell |
5,691
-84
| -1% | -$1.06K | ﹤0.01% | 1485 |
|
|
2024
Q4 | $60.9K | Buy |
5,775
+84
| +1% | +$886 | ﹤0.01% | 1627 |
|
|
2024
Q3 | $82.5K | Hold |
5,691
| – | – | ﹤0.01% | 1502 |
|
|
2024
Q2 | $48.4K | Buy |
5,691
+91
| +2% | +$774 | ﹤0.01% | 1680 |
|
|
2024
Q1 | $57.2K | Hold |
5,600
| – | – | ﹤0.01% | 1620 |
|
|
2023
Q4 | $30.7K | Buy |
5,600
+5,575
| +22,300% | +$30.6K | ﹤0.01% | 1750 |
|
|
2023
Q3 | $95 | Buy |
+25
| New | +$95 | ﹤0.01% | 2736 |
|
|
2022
Q2 | – | Sell |
-4,100
| Closed | -$14K | – | 2500 |
|
|
2022
Q1 | $14K | Buy |
+4,100
| New | +$14K | ﹤0.01% | 2141 |
|